Clinical Trial

Trial of Venovenous ECMO to De-Sedate, Extubate and Mobilise in Hypoxic Respiratory Failure

Study acronym: REDEEM
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 9, 2024 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
To determine whether a strategy of adding venovenous ECMO to mechanical ventilation, as compared to mechanical ventilation alone, increases the number of intensive care free days at day 60, in patients with moderate to severe acute hypoxic respiratory failure.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-09-26.
Status change: Not Yet Recruiting → Recruiting 2024-08-06
Trial Details
NCT Number NCT05562505
Lead Sponsor Australian and New Zealand Intensive Care Research Centre
Collaborators: The Alfred
Conditions Mechanical Ventilation Complication, Hypoxemia, Acute Respiratory Distress Syndrome Due to COVID-19, COVID-19 Respiratory Infection, Pneumonia, Extracorporeal Membrane Oxygenation
Enrollment 140 participants
Start Date 2022-11-28
Primary Completion 2026-07-31 (estimated)
Study Completion 2027-01-31 (estimated)
Updated on ClinicalTrials.gov 2024-08-09